Description

HearTwave II Cardiac Diagnostic System for sale

The HearTwave II system is a state-of-the-art stress testing platform that includes Cambridge Heart’s proprietary Microvolt T-Wave Alternanstm (MTWA) option, the only Medicare-reimbursable MTWA test on the market.
Microvolt T-Wave Alternans (MTWA) enhances stress testing by incorporating a non-invasive, clinically-proven, reimbursable test that can help identify patients at risk for Sudden Cardiac Arrest (SCA).
This comprehensive solution enables you to assess both ischemic and arrhythmic risk, allowing you to determine the best overall risk management strategy for your patients.
Features:
• MTWA: A simple non-invasive test that can easily become part of your stress regimen for nuclear, echo and standard treadmill procedures.
• A state-of-the-art stress system with patented high-fidelity trace quality, patented diagnostic ECG grid, customized protocols, full disclosure, network connectivity, wireless and laser printer options, and compatibility with most treadmills, NIBP and echo systems